The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Cyclopentyl-2-(3,4-dichlorophenyl)-N-(4-methyl-thiazol-2-yl)-propionamide ID: ALA1094752
PubChem CID: 22315184
Max Phase: Preclinical
Molecular Formula: C18H20Cl2N2OS
Molecular Weight: 383.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1csc(NC(=O)C(CC2CCCC2)c2ccc(Cl)c(Cl)c2)n1
Standard InChI: InChI=1S/C18H20Cl2N2OS/c1-11-10-24-18(21-11)22-17(23)14(8-12-4-2-3-5-12)13-6-7-15(19)16(20)9-13/h6-7,9-10,12,14H,2-5,8H2,1H3,(H,21,22,23)
Standard InChI Key: CHLIYNONVQVQKB-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
-0.4032 -14.3820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1195 -13.9702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1225 -13.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4023 -15.2046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3101 -13.9675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1115 -15.1976 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0243 -14.3756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7744 -14.0380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3304 -14.6519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9187 -15.3682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1503 -14.5612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8328 -14.3847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8299 -15.2109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5432 -15.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2595 -15.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2625 -14.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5491 -13.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9728 -15.6281 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.5423 -16.4480 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.4091 -12.7296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3243 -11.9107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4812 -11.7352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8957 -12.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3464 -13.0650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
6 10 1 0
9 11 1 0
5 7 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
15 18 1 0
14 19 1 0
2 12 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
20 24 1 0
3 20 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.34Molecular Weight (Monoisotopic): 382.0673AlogP: 6.06#Rotatable Bonds: 5Polar Surface Area: 41.99Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.90CX Basic pKa: ┄CX LogP: 5.87CX LogD: 5.76Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.68Np Likeness Score: -1.47
References 1. Haynes NE, Corbett WL, Bizzarro FT, Guertin KR, Hilliard DW, Holland GW, Kester RF, Mahaney PE, Qi L, Spence CL, Tengi J, Dvorozniak MT, Railkar A, Matschinsky FM, Grippo JF, Grimsby J, Sarabu R.. (2010) Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)., 53 (9): [PMID:20405948 ] [10.1021/jm100039a ]